Temat: "Ki-67" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy for human epidermal growth factor receptor 2 positive breast cancer: a real-world retrospective single-institutional study in China.
Autorzy:: Peng DM; Department of Breast Surgery, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, NO, Shenyang, 110042, P.R. China.
Li J; Department of Breast Surgery, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, NO, Shenyang, 110042, P.R. China.
Qiu JX; Department of Breast Surgery, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, NO, Shenyang, 110042, P.R. China.
Zhao L; Department of Breast Surgery, Liaoning Cancer Hospital & Institute, 44 Xiaoheyan Road, NO, Shenyang, 110042, P.R. China. .; Pokaż więcej
Źródło:: World journal of surgical oncology [World J Surg Oncol] 2024 Apr 06; Vol. 22 (1), pp. 88. Date of Electronic Publication: 2024 Apr 06.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Antibodies, Monoclonal, Humanized*
Humans ; Female ; Trastuzumab/therapeutic use ; Trastuzumab/adverse effects ; Neoadjuvant Therapy/adverse effects ; Retrospective Studies ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/metabolism ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis.
Autorzy:: Bahrin NWS; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam.
Matusin SNI; Halalan Thayyiban Research Centre, Universiti Islam Sultan Sharif Ali, Jalan Tutong, Sinaut, TB1741, Negara Brunei Darussalam.
Mustapa A; Halalan Thayyiban Research Centre, Universiti Islam Sultan Sharif Ali, Jalan Tutong, Sinaut, TB1741, Negara Brunei Darussalam.
Huat LZ; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam.
Perera S; Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka.
Hamid MRWHA; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam. .; Pokaż więcej
Źródło:: Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 100. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Bridged-Ring Compounds*
Humans ; Female ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Taxoids/therapeutic use ; Receptors, Estrogen/genetics ; Receptors, Estrogen/metabolism ; Receptors, Estrogen/therapeutic use ; Class I Phosphatidylinositol 3-Kinases/therapeutic use ; Genetic Variation ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Stromal Ki67 Expression Might be a Useful Marker for Distinguishing Fibroadenoma From Benign Phyllodes Tumor of the Breast.
Autorzy:: Yuan M; Juntendo University School of Medicine, Tokyo, Japan.
Saeki H; Juntendo University School of Medicine, Tokyo, Japan.
Horimoto Y; Juntendo University School of Medicine, Tokyo, Japan.
Ishizuka Y; Juntendo University School of Medicine, Tokyo, Japan.
Onagi H; Juntendo University School of Medicine, Tokyo, Japan.
Saito M; Juntendo University School of Medicine, Tokyo, Japan.
Hayashi T; Juntendo University School of Medicine, Tokyo, Japan.
Arakawa A; Juntendo University School of Medicine, Tokyo, Japan.
Yao T; Juntendo University School of Medicine, Tokyo, Japan.; Pokaż więcej
Źródło:: International journal of surgical pathology [Int J Surg Pathol] 2024 Apr; Vol. 32 (2), pp. 223-229. Date of Electronic Publication: 2023 May 08.
Typ publikacji:: Journal Article
MeSH Terms:: Phyllodes Tumor*/diagnosis
Fibroadenoma*/diagnosis
Breast Neoplasms*/diagnosis
Fibroma*
Humans ; Female ; Ki-67 Antigen ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients.
Autorzy:: Wang M; The Second Hospital of Dalian Medical University, Dalian, 116023, China. mijia_.
Wei Z; The Second Hospital of Dalian Medical University, Dalian, 116023, China.
Kong J; The Second Hospital of Dalian Medical University, Dalian, 116023, China.
Zhao H; The Second Hospital of Dalian Medical University, Dalian, 116023, China. .; Pokaż więcej
Źródło:: Diagnostic pathology [Diagn Pathol] 2024 Mar 20; Vol. 19 (1), pp. 53. Date of Electronic Publication: 2024 Mar 20.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Biomarkers, Tumor/analysis ; Ki-67 Antigen/analysis ; Neoadjuvant Therapy ; Prognosis ; ErbB Receptors ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Receptor, ErbB-2/metabolism ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Changes in Invasive Breast Carcinomas after Neoadjuvant Chemotherapy Can Influence Adjuvant Therapeutic Decisions.
Autorzy:: Jaime Dos Santos B; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Balabram D; Department of Surgery, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Mara Reis Gomes V; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Costa Café de Castro C; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Henrique Costa Diniz P; Department of Medical Clinic, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
Araújo Buzelin M; Institute of Teaching and Research of Santa Casa de Belo Horizonte, Belo Horizonte, Brazil.
Buzelin Nunes C; Laboratory of Mammary Pathology, Department of Anatomical Pathology and Forensic Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.; Pokaż więcej
Źródło:: Cancer research and treatment [Cancer Res Treat] 2024 Jan; Vol. 56 (1), pp. 178-190. Date of Electronic Publication: 2023 Aug 01.
Typ publikacji:: Journal Article
MeSH Terms:: Neoadjuvant Therapy*
Breast Neoplasms*/pathology
Humans ; Female ; Ki-67 Antigen ; Receptor, ErbB-2/metabolism ; Neoplasm Grading ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Chemotherapy, Adjuvant ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Real-world data on neoadjuvant chemotherapy with dual-anti HER2 therapy in HER2 positive breast cancer.
Autorzy:: Yang ZJ; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, He-Xi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Xin F; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, He-Xi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Chen ZJ; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, He-Xi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Yu Y; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, He-Xi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Wang X; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, He-Xi District, Tianjin, 300060, China.; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China.; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China.; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China.
Cao XC; The First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Huan-Hu-Xi Road, He-Xi District, Tianjin, 300060, China. .; Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China. .; Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education, Tianjin, 300060, China. .; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 25; Vol. 24 (1), pp. 134. Date of Electronic Publication: 2024 Jan 25.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Humans ; Female ; Neoadjuvant Therapy ; Treatment Outcome ; Receptor, ErbB-2/metabolism ; Ki-67 Antigen ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: AI improves accuracy, agreement and efficiency of pathologists for Ki67 assessments in breast cancer.
Autorzy:: Dy A; Electrical, Computer, and Biomedical Engineering, Toronto Metropolitan University, Toronto, ON, Canada. .
Nguyen NJ; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
Meyer J; School of Health Services Management, Toronto Metropolitan University, Toronto, ON, Canada.
Dawe M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Shi W; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Androutsos D; Electrical, Computer, and Biomedical Engineering, Toronto Metropolitan University, Toronto, ON, Canada.
Fyles A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Liu FF; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Done S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Khademi A; Electrical, Computer, and Biomedical Engineering, Toronto Metropolitan University, Toronto, ON, Canada.; Keenan Research Center for Biomedical Science, St. Michael's Hospital, Unity Health Network, Toronto, ON, Canada.; Institute for Biomedical Engineering, Science Tech (iBEST), A Partnership Between St. Michael's Hospital and Toronto Metropolitan University, Toronto, ON, Canada.; Vector Institute for Artificial Intelligence, Toronto, ON, Canada.; Department of Medical Imaging, University of Toronto, Toronto, ON, Canada.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Jan 13; Vol. 14 (1), pp. 1283. Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*
Humans ; Female ; Ki-67 Antigen ; Pathologists ; Reproducibility of Results ; Immunohistochemistry

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: BRCA1 and BRCA2 germline mutations in Chinese Hakka breast cancer patients.
Autorzy:: Zhang Y; Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, No 63 Huangtang Road, Meijiang District, Meizhou, 514031, P. R. China.; Guangdong Engineering Technological Research Center of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou, China.
Wu H; Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, No 63 Huangtang Road, Meijiang District, Meizhou, 514031, P. R. China.
Gan C; Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, No 63 Huangtang Road, Meijiang District, Meizhou, 514031, P. R. China.; Guangdong Engineering Technological Research Center of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou, China.
Rao H; Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, No 63 Huangtang Road, Meijiang District, Meizhou, 514031, P. R. China.
Wang Q; Department of Medical Oncology, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, Meizhou, People's Republic of China.
Guo X; Center for Precision Medicine, Meizhou People's Hospital (Huangtang Hospital), Meizhou Academy of Medical Sciences, No 63 Huangtang Road, Meijiang District, Meizhou, 514031, P. R. China. .; Guangdong Engineering Technological Research Center of Clinical Molecular Diagnosis and Antibody Drugs, Meizhou, China. .; Pokaż więcej
Źródło:: BMC medical genomics [BMC Med Genomics] 2024 Jan 02; Vol. 17 (1), pp. 3. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Female ; Humans ; BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; China/epidemiology ; Genetic Predisposition to Disease ; Germ-Line Mutation ; Ki-67 Antigen/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China: results from a pilot work of National Single Disease Quality Control Program for breast cancer.
Autorzy:: Xue X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Guo L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Guo C; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Li L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yang L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang X; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Rao W; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yuan P; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Mu J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Li J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Wang B; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Zhou Q; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.
Yang W; Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, 200032, China.
Liu Y; Department of Pathology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, 050011, China.
Xue W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, 100142, China.
Jia R; Special Standard Laboratory Accreditation Department, National Accreditation Service for Conformity Assessment, 8 Nanhuashi Street, Dongcheng District, Beijing, 100062, China. .
Yang W; Office for Cancer Diagnosis and Treatment Quality Control, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .
Ying J; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 02; Vol. 24 (1), pp. 23. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/metabolism ; Immunohistochemistry ; Receptors, Estrogen/metabolism ; Laboratory Proficiency Testing ; Receptors, Progesterone/metabolism ; Biomarkers, Tumor/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Molecular features of luminal breast cancer defined through spatial and single-cell transcriptomics.
Autorzy:: Yoshitake R; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
Mori H; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.; Department of Surgery and Oncology, Graduate School of Medicine, Kyushu University, Fukuoka, Japan.
Ha D; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
Wu X; Integrative Genomics Core, Beckman Research Institute of City of Hope, Monrovia, California, USA.
Wang J; Integrative Genomics Core, Beckman Research Institute of City of Hope, Monrovia, California, USA.
Wang X; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
Saeki K; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.; Faculty of Veterinary Medicine, Okayama University of Science, Imabari, Ehime, Japan.
Chang G; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
Shim HJ; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
Chan Y; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.
Chen S; Department of Cancer Biology and Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, California, USA.; Pokaż więcej
Źródło:: Clinical and translational medicine [Clin Transl Med] 2024 Jan; Vol. 14 (1), pp. e1548.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Breast Neoplasms*/genetics
Breast Neoplasms*/pathology
Humans ; Female ; Ki-67 Antigen/genetics ; Receptors, Estrogen/genetics ; Gene Expression Profiling ; Estrogens ; Inflammation ; Hypoxia

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: [The expression of Plakoglobin in residual cancer after neoadjuvant chemotherapy for breast cancer and its prognostic impact on patients].
Autorzy:: Li Y; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Guo L; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Guo CY; Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Lei CQ; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Zhang K; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang NC; Department of Cancer Prevention, Office of Cancer Screening, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Wang ZZ; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Xuan LX; Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.; Pokaż więcej
Źródło:: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2023 Dec 23; Vol. 45 (12), pp. 1057-1064.
Typ publikacji:: English Abstract; Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/surgery
Humans ; Female ; Prognosis ; Ki-67 Antigen/analysis ; Neoadjuvant Therapy/methods ; gamma Catenin ; Neoplasm, Residual ; Disease-Free Survival ; Retrospective Studies ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Correlation between dynamic contrast-enhanced MRI characteristics and apparent diffusion coefficient with Ki-67-positive expression in non-mass enhancement of breast cancer.
Autorzy:: Nie T; Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 116 Zhuodaoquan South Load, Hongshan District, Wuhan, 430079, Hubei, China.
Feng M; Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 116 Zhuodaoquan South Load, Hongshan District, Wuhan, 430079, Hubei, China.
Yang K; Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 116 Zhuodaoquan South Load, Hongshan District, Wuhan, 430079, Hubei, China.
Guo X; Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 116 Zhuodaoquan South Load, Hongshan District, Wuhan, 430079, Hubei, China.
Yuan Z; Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 116 Zhuodaoquan South Load, Hongshan District, Wuhan, 430079, Hubei, China.
Zhang Z; Department of Radiology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, No 116 Zhuodaoquan South Load, Hongshan District, Wuhan, 430079, Hubei, China. .
Yan G; Department of Radiology, the Second Affiliated Hospital of Xiamen Medical College, No 566 Shengguang Road, Jimei District, Xiamen, 361000, Fujian, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Dec 05; Vol. 13 (1), pp. 21451. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Ki-67 Antigen ; Retrospective Studies ; Contrast Media ; Magnetic Resonance Imaging/methods ; Diffusion Magnetic Resonance Imaging/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Prognostic impact of HER2-low positivity in patients with HR-positive, HER2-negative, node-positive early breast cancer.
Autorzy:: Shikata S; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Murata T; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan. .
Yoshida M; Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Hashiguchi H; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yoshii Y; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Ogawa A; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Watase C; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Shiino S; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Sugino H; Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Jimbo K; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Maeshima A; Department of Diagnostic Pathology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Iwamoto E; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Takayama S; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Suto A; Department of Breast Surgery, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Nov 11; Vol. 13 (1), pp. 19669. Date of Electronic Publication: 2023 Nov 11.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/pathology
Humans ; Female ; Prognosis ; Ki-67 Antigen ; Retrospective Studies ; Neoplasm Recurrence, Local ; Receptor, ErbB-2/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Elevated profiles of peripheral Th22, Th17, Th2 cells, and decreased percentage of Th1 cells in breast cancer patients.
Autorzy:: Peng Z; Department of Organ Transplantation, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Dong X; Department of Oncology, Qilu Hospital of Shandong University Dezhou Hospital, Dezhou, China.
He M; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Zhao Y; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Liu Y; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li M; Department of Oncology, Weifang People's Hospital, Weifang, China.
Li G; Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Wang X; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Li L; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.
Hu Y; Department of Medical Oncology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.; Pokaż więcej
Źródło:: Thoracic cancer [Thorac Cancer] 2023 Nov; Vol. 14 (33), pp. 3282-3294. Date of Electronic Publication: 2023 Sep 21.
Typ publikacji:: Journal Article
MeSH Terms:: Th1 Cells*/metabolism
Breast Neoplasms*/metabolism
Humans ; Female ; Th2 Cells ; Ki-67 Antigen/metabolism ; Cytokines/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: NOXA expression is downregulated in human breast cancer undergoing incomplete pathological response and senescence after neoadjuvant chemotherapy.
Autorzy:: Al Shboul S; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan.
El-Sadoni M; Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, 11942, Jordan.
Alhesa A; Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, 11942, Jordan.
Abu Shahin N; Department of Pathology, Microbiology and Forensic Medicine, School of Medicine, The University of Jordan, Amman, 11942, Jordan.
Abuquteish D; Department of Microbiology, Pathology and Forensic Medicine, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan.
Abu Al Karsaneh O; Department of Microbiology, Pathology and Forensic Medicine, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan.
Alsharaiah E; Department of Pathology, King Hussein Medical Center, Royal Medical Service, Amman, 11942, Jordan.
Ismail MA; Cell Therapy Center, The University of Jordan, Amman, 11942, Jordan.
Tyutyunyk-Massey L; Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
Alotaibi MR; Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Neely V; Philips Institute for Oral Health Research, School of Dentistry, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Harada H; Philips Institute for Oral Health Research, School of Dentistry, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, USA.
Saleh T; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, 13133, Jordan. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2023 Sep 23; Vol. 13 (1), pp. 15903. Date of Electronic Publication: 2023 Sep 23.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Breast Neoplasms*/metabolism
Female ; Humans ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cyclin-Dependent Kinase Inhibitor p16 ; Ki-67 Antigen/metabolism ; Neoadjuvant Therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy.
Autorzy:: Oner G; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Department of General Surgery, Kocaeli University, Kocaeli, Turkey.
Broeckx G; Department of Histopathology, Antwerp University Hospital, Edegem, Belgium.
Van Berckelaer C; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Zwaenepoel K; Department of Histopathology, Antwerp University Hospital, Edegem, Belgium.
Altintas S; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Canturk Z; Department of General Surgery, Kocaeli University, Kocaeli, Turkey.
Tjalma W; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Berneman Z; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Department of Hematology, Antwerp University Hospital, Edegem, Belgium.
Peeters M; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.
Pauwels P; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Department of Histopathology, Antwerp University Hospital, Edegem, Belgium.
van Dam PA; Multidisciplinary Oncologic Centre Antwerp (MOCA), Antwerp University Hospital, Edegem, Belgium.; Center for Oncological Research (CORE), University of Antwerp, Wilrijk, Belgium.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Sep; Vol. 12 (17), pp. 17901-17913. Date of Electronic Publication: 2023 Aug 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms*/pathology
Triple Negative Breast Neoplasms*/pathology
Humans ; Middle Aged ; Female ; Neoadjuvant Therapy/methods ; Aromatase Inhibitors/therapeutic use ; Ki-67 Antigen ; Phosphatidylinositol 3-Kinases ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment ; Prognosis ; Biomarkers, Tumor

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Survey of clinicians on the use of adjuvant therapy for premenopausal women with breast cancer.
Autorzy:: Lee YW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ahn SH; Department of Surgery, Ewha Womans University College of Medicine, Ewha Womans University Mokdong Hospital, Seoul, Republic of Korea.
Lee YJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Yoo TK; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim J; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Chung IY; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Kim HJ; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Ko BS; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee JW; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Son BH; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
Lee SB; Division of Breast Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2023 Aug 17; Vol. 18 (8), pp. e0290174. Date of Electronic Publication: 2023 Aug 17 (Print Publication: 2023).
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/drug therapy
Breast Neoplasms*/genetics
Humans ; Female ; Aged ; Adult ; Middle Aged ; Ki-67 Antigen ; Combined Modality Therapy ; Chemotherapy, Adjuvant ; Tamoxifen/therapeutic use ; Aromatase Inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Calcium-Sensing Receptor Expression in Breast Cancer.
Autorzy:: Busic-Pavlek I; Clinical Department of Diagnostic and Interventional Radiology, University Hospital Centre Split, Spinciceva 1, 21000 Split, Croatia.
Dumic-Cule I; Clinical Department of Diagnostic and Interventional Radiology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.; Department of Nursing, University North, 104 Brigade 3, 42000 Varazdin, Croatia.
Kovacevic L; Clinical Department of Diagnostic and Interventional Radiology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
Milosevic M; Department of Environmental Health and Occupational and Sports Medicine, Andrija Stampar School of Public Health, Rockfellerova 4, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, Salata 3, 10000 Zagreb, Croatia.
Delimar P; Clinical Department of Diagnostic and Interventional Radiology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
Korsa L; Clinical Department of Pathology and Cytology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
Marusic Z; Clinical Department of Pathology and Cytology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.
Prutki M; Clinical Department of Diagnostic and Interventional Radiology, University Hospital Centre Zagreb, Kispaticeva 12, 10000 Zagreb, Croatia.; School of Medicine, University of Zagreb, Salata 3, 10000 Zagreb, Croatia.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 20; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 20.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*/metabolism
Receptors, Calcium-Sensing*/genetics
Female ; Humans ; Biomarkers, Tumor/metabolism ; Ki-67 Antigen/genetics ; Ki-67 Antigen/metabolism ; Receptor, ErbB-2/metabolism ; Receptors, Progesterone/metabolism ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Fate of Entosis: From the Beginning to the End in Untreated Advanced Breast Cancer.
Autorzy:: Dziuba I; Department of Pathology, Faculty of Medicine, Academy of Silesia, 40-555 Katowice, Poland.
Gawel AM; Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Medical University of Warsaw, 02-004 Warsaw, Poland.
Tyrna P; Histology and Embryology Students' Science Association, Department of Histology and Embryology, Faculty of Medicine, Medical University of Warsaw, 02-004 Warsaw, Poland.
Rybczynska J; Department of Histology and Embryology, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University in Warsaw, 01-815 Warsaw, Poland.
Bialy LP; Department of Histology and Embryology, Faculty of Medicine, Medical University of Warsaw, 02-004 Warsaw, Poland.
Mlynarczuk-Bialy I; Department of Histology and Embryology, Faculty of Medicine, Medical University of Warsaw, 02-004 Warsaw, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 Jul 29; Vol. 24 (15). Date of Electronic Publication: 2023 Jul 29.
Typ publikacji:: Journal Article
MeSH Terms:: Breast Neoplasms*
Humans ; Female ; Entosis/physiology ; Ki-67 Antigen ; Cell Death

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Selection of optimal quantile protein biomarkers based on cell-level immunohistochemistry data.
Autorzy:: Yi M; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA. .
Zhan T; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA.
Peck AR; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Hooke JA; John P. Murtha Cancer Center, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.
Kovatich AJ; John P. Murtha Cancer Center, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.
Shriver CD; John P. Murtha Cancer Center, Uniformed Services University and Walter Reed National Military Medical Center, Bethesda, MD, USA.
Hu H; Chan Soon-Shiong Institute of Molecular Medicine at Windber, Windber, PA, USA.
Sun Y; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Rui H; Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Chervoneva I; Division of Biostatistics, Department of Pharmacology and Experimental Therapeutics, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, 19107, USA. .; Pokaż więcej
Źródło:: BMC bioinformatics [BMC Bioinformatics] 2023 Jul 22; Vol. 24 (1), pp. 298. Date of Electronic Publication: 2023 Jul 22.
Typ publikacji:: Journal Article
MeSH Terms:: Biomarkers, Tumor*
Breast Neoplasms*
Humans ; Female ; Immunohistochemistry ; Ki-67 Antigen ; Algorithms

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Ki-67"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji